Can We Screen for Postpartum Depression Earlier?
Several studies suggest that screening during the first week postpartum may be helpful in identifying women at higher risk for experiencing postpartum depression.
Several studies suggest that screening during the first week postpartum may be helpful in identifying women at higher risk for experiencing postpartum depression.
This study provides valuable insight into the inequities in perinatal mental healthcare and suggests that the most significant barriers to mental healthcare may occur at the provider referral level.
A study using indirect comparisons suggests that zuranolone is more effective than the SSRIs for the treatment of PPD. Should it be the first choice for treatment?
Although up to 10% of new fathers may experience mental health challenges, we do not regularly screen this population.
Individuals with postpartum depression are being recruited for a clinical trial of a novel psychedelic compound, RE104.
There is little published data on the use of St. John's wort during breastfeeding and because we lack data, we would typically recommend using a conventional antidepressant, such as an SSRI or SNRI.Â
Further studies are needed to determine whether ketamine and esketamine are effective for the treatment of postpartum depression.
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on access to perinatal mental healthcare with Ob.Gyn News on May 23, 2024.
List of resources for families with infants in the Neonatal Intensive Care Unit.
May 1, 2024 is World Maternal Mental Health Day, coming together to increase awareness of perinatal mood and anxiety disorders.